25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

GNLX (Genelux) Stock Analysis
Buy, Hold or Sell?

Let's analyze Genelux together

I guess you are interested in Genelux Corporation Common Stock. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Genelux’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Genelux’s Price Targets

I'm going to help you getting a better view of Genelux Corporation Common Stock. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Genelux Corporation Common Stock

I send you an email if I find something interesting about Genelux Corporation Common Stock.

1. Quick Overview

1.1. Quick analysis of Genelux (30 sec.)










1.2. What can you expect buying and holding a share of Genelux? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.79
Expected worth in 1 year
$1.18
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
$0.39
Return On Investment
11.6%

For what price can you sell your share?

Current Price per Share
$3.38
Expected price per share
$3.17 - $5.67
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Genelux (5 min.)




Live pricePrice per Share (EOD)
$3.38
Intrinsic Value Per Share
$-13.86 - $-16.48
Total Value Per Share
$-13.06 - $-15.69

2.2. Growth of Genelux (5 min.)




Is Genelux growing?

Current yearPrevious yearGrowGrow %
How rich?$29.8m$20.2m$11.5m36.3%

How much money is Genelux making?

Current yearPrevious yearGrowGrow %
Making money-$7.3m-$6.4m-$932k-12.6%
Net Profit Margin-414.4%-24,646.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Genelux (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Genelux?

Welcome investor! Genelux's management wants to use your money to grow the business. In return you get a share of Genelux.

First you should know what it really means to hold a share of Genelux. And how you can make/lose money.

Speculation

The Price per Share of Genelux is $3.38. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Genelux.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Genelux, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.79. Based on the TTM, the Book Value Change Per Share is $0.10 per quarter. Based on the YOY, the Book Value Change Per Share is $0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Genelux.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.20-5.9%-0.20-5.8%-0.17-5.1%-0.15-4.4%-0.13-3.8%-0.13-3.8%
Usd Book Value Change Per Share0.092.8%0.102.9%0.082.4%0.154.3%0.051.4%0.041.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.092.8%0.102.9%0.082.4%0.154.3%0.051.4%0.041.1%
Usd Price Per Share2.70-2.35-19.41-9.56-5.74-5.47-
Price to Earnings Ratio-3.40--3.03--30.88--13.41--8.04--7.66-
Price-to-Total Gains Ratio28.52--0.20-103.32-48.85-48.85-48.85-
Price to Book Ratio3.41-2.86-34.29-44.80-26.88-25.60-
Price-to-Total Gains Ratio28.52--0.20-103.32-48.85-48.85-48.85-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.38
Number of shares295
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.100.05
Usd Total Gains Per Share0.100.05
Gains per Quarter (295 shares)28.8513.88
Gains per Year (295 shares)115.4055.52
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1011510505646
202312200111102
303463350167158
404624500222214
505775650278270
606926800333326
708087950389382
809239100444438
90103910250500494
100115411400555550

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%1.020.00.04.8%1.020.00.04.8%
Book Value Change Per Share2.02.00.050.0%6.06.00.050.0%7.09.04.035.0%7.010.04.033.3%7.010.04.033.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.021.00.0%0.00.021.00.0%
Total Gains per Share2.02.00.050.0%6.06.00.050.0%7.09.04.035.0%7.010.04.033.3%7.010.04.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Genelux Corporation Common Stock compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0950.098-3%0.082+15%0.147-35%0.047+101%0.038+151%
Book Value Per Share--0.7910.841-6%0.536+48%0.228+247%-0.033+104%-0.039+105%
Current Ratio--4.6755.432-14%3.403+37%3.073+52%2.049+128%1.989+135%
Debt To Asset Ratio--0.2340.206+14%0.319-26%1.824-87%2.646-91%2.645-91%
Debt To Equity Ratio--0.3060.261+17%0.474-35%0.614-50%0.369-17%0.351-13%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--127847500.000113843575.000+12%748196687.500-83%499260327.778-74%499260327.778-74%499260327.778-74%
Eps---0.199-0.196-2%-0.171-14%-0.148-26%-0.129-35%-0.128-36%
Ev To Ebitda Ratio---4.163-3.980-4%-33.202+697%-19.641+372%-19.641+372%-19.641+372%
Ev To Sales Ratio--70.71270.7120%3994.385-98%2399.129-97%2399.129-97%2399.129-97%
Free Cash Flow Per Share---0.145-0.150+4%-0.139-4%-0.121-16%-0.085-41%-0.083-43%
Free Cash Flow To Equity Per Share--0.1090.097+12%0.060+81%0.059+83%0.029+274%0.028+293%
Gross Profit Margin--1.0001.008-1%1.015-2%1.008-1%1.0050%1.006-1%
Intrinsic Value_10Y_max---16.481----------
Intrinsic Value_10Y_min---13.855----------
Intrinsic Value_1Y_max---0.654----------
Intrinsic Value_1Y_min---0.642----------
Intrinsic Value_3Y_max---2.725----------
Intrinsic Value_3Y_min---2.586----------
Intrinsic Value_5Y_max---5.713----------
Intrinsic Value_5Y_min---5.237----------
Market Cap127544300.000+20%101884500.00088488575.000+15%732530687.500-86%360903829.167-72%216542297.500-53%206230759.524-51%
Net Profit Margin---16.575-4.144-75%-246.468+1387%-92.565+458%-55.539+235%-52.894+219%
Operating Margin---17.292-4.323-75%-246.467+1325%-92.032+432%-55.219+219%-52.590+204%
Operating Ratio--18.2924.573+300%255.039-93%94.124-81%56.474-68%53.785-66%
Pb Ratio4.273+20%3.4142.865+19%34.293-90%44.802-92%26.881-87%25.601-87%
Pe Ratio-4.256-25%-3.400-3.034-11%-30.877+808%-13.408+294%-8.045+137%-7.662+125%
Price Per Share3.380+20%2.7002.345+15%19.413-86%9.564-72%5.739-53%5.465-51%
Price To Free Cash Flow Ratio-5.835-25%-4.661-4.051-13%-37.245+699%-18.406+295%-11.044+137%-10.518+126%
Price To Total Gains Ratio35.707+20%28.523-0.204+101%103.320-72%48.852-42%48.852-42%48.852-42%
Quick Ratio--7.0239.034-22%4.251+65%4.528+55%2.909+141%2.808+150%
Return On Assets---0.192-0.189-2%-0.226+17%-0.206+7%-0.564+194%-0.589+206%
Return On Equity---0.251-0.241-4%-0.338+35%-0.514+105%-0.308+23%-0.294+17%
Total Gains Per Share--0.0950.098-3%0.082+15%0.147-35%0.047+101%0.038+151%
Usd Book Value--29846000.00031720000.000-6%20210250.000+48%8602916.667+247%-1260037.500+104%-1469738.095+105%
Usd Book Value Change Per Share--0.0950.098-3%0.082+15%0.147-35%0.047+101%0.038+151%
Usd Book Value Per Share--0.7910.841-6%0.536+48%0.228+247%-0.033+104%-0.039+105%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--127847500.000113843575.000+12%748196687.500-83%499260327.778-74%499260327.778-74%499260327.778-74%
Usd Eps---0.199-0.196-2%-0.171-14%-0.148-26%-0.129-35%-0.128-36%
Usd Free Cash Flow---5465000.000-5672500.000+4%-5246250.000-4%-4567000.000-16%-3199887.500-41%-3129607.143-43%
Usd Free Cash Flow Per Share---0.145-0.150+4%-0.139-4%-0.121-16%-0.085-41%-0.083-43%
Usd Free Cash Flow To Equity Per Share--0.1090.097+12%0.060+81%0.059+83%0.029+274%0.028+293%
Usd Market Cap127544300.000+20%101884500.00088488575.000+15%732530687.500-86%360903829.167-72%216542297.500-53%206230759.524-51%
Usd Price Per Share3.380+20%2.7002.345+15%19.413-86%9.564-72%5.739-53%5.465-51%
Usd Profit---7492000.000-7377750.000-2%-6445750.000-14%-5570083.333-26%-4879462.500-35%-4826726.190-36%
Usd Revenue--452000.000113000.000+300%368000.000+23%1096833.333-59%658100.000-31%626761.905-28%
Usd Total Gains Per Share--0.0950.098-3%0.082+15%0.147-35%0.047+101%0.038+151%
 EOD+6 -2MRQTTM+14 -23YOY+22 -163Y+17 -215Y+21 -1710Y+21 -17

3.3 Fundamental Score

Let's check the fundamental score of Genelux Corporation Common Stock based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.256
Price to Book Ratio (EOD)Between0-14.273
Net Profit Margin (MRQ)Greater than0-16.575
Operating Margin (MRQ)Greater than0-17.292
Quick Ratio (MRQ)Greater than17.023
Current Ratio (MRQ)Greater than14.675
Debt to Asset Ratio (MRQ)Less than10.234
Debt to Equity Ratio (MRQ)Less than10.306
Return on Equity (MRQ)Greater than0.15-0.251
Return on Assets (MRQ)Greater than0.05-0.192
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Genelux Corporation Common Stock based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.130
Ma 20Greater thanMa 503.067
Ma 50Greater thanMa 1002.759
Ma 100Greater thanMa 2003.054
OpenGreater thanClose3.410
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Genelux Corporation Common Stock

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary modified strain of the vaccinia virus indicated for the treatment of ovarian cancer and non-small cell lung cancer, as well as for liquid or solid tumors, appendiceal, colorectal and gastric cancers, other gynecologic malignancies, and peritoneal mesothelioma. The company has a licensing agreement with Newsoara BioPharma Co. Ltd. to research, develop, commercialize or exploit Olvi-Vec in China, including Mainland China, Taiwan, Hong Kong, and Macau, for human diagnostic, prophylactic, and therapeutic uses. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California.

Fundamental data was last updated by Penke on 2025-06-25 11:28:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Genelux earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Genelux to theΒ Biotechnology industry mean.
  • A Net Profit Margin of -1,657.5%Β means thatΒ $-16.58 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Genelux Corporation Common Stock:

  • The MRQ is -1,657.5%. The company is making a huge loss. -2
  • The TTM is -414.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,657.5%TTM-414.4%-1,243.1%
TTM-414.4%YOY-24,646.8%+24,232.4%
TTM-414.4%5Y-5,553.9%+5,139.5%
5Y-5,553.9%10Y-5,289.4%-264.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,657.5%-90.3%-1,567.2%
TTM-414.4%-139.0%-275.4%
YOY-24,646.8%-195.4%-24,451.4%
3Y-9,256.5%-247.7%-9,008.8%
5Y-5,553.9%-344.1%-5,209.8%
10Y-5,289.4%-488.1%-4,801.3%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Genelux is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Genelux to theΒ Biotechnology industry mean.
  • -19.2% Return on Assets means thatΒ Genelux generatedΒ $-0.19 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Genelux Corporation Common Stock:

  • The MRQ is -19.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -18.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-19.2%TTM-18.9%-0.3%
TTM-18.9%YOY-22.6%+3.7%
TTM-18.9%5Y-56.4%+37.5%
5Y-56.4%10Y-58.9%+2.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-19.2%-11.5%-7.7%
TTM-18.9%-11.5%-7.4%
YOY-22.6%-11.4%-11.2%
3Y-20.6%-11.7%-8.9%
5Y-56.4%-11.9%-44.5%
10Y-58.9%-13.6%-45.3%
4.3.1.3. Return on Equity

Shows how efficient Genelux is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Genelux to theΒ Biotechnology industry mean.
  • -25.1% Return on Equity means Genelux generated $-0.25Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Genelux Corporation Common Stock:

  • The MRQ is -25.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -24.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-25.1%TTM-24.1%-1.0%
TTM-24.1%YOY-33.8%+9.7%
TTM-24.1%5Y-30.8%+6.8%
5Y-30.8%10Y-29.4%-1.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-25.1%-13.6%-11.5%
TTM-24.1%-14.8%-9.3%
YOY-33.8%-14.4%-19.4%
3Y-51.4%-16.8%-34.6%
5Y-30.8%-17.5%-13.3%
10Y-29.4%-19.5%-9.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Genelux Corporation Common Stock.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Genelux is operatingΒ .

  • Measures how much profit Genelux makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Genelux to theΒ Biotechnology industry mean.
  • An Operating Margin of -1,729.2%Β means the company generated $-17.29 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Genelux Corporation Common Stock:

  • The MRQ is -1,729.2%. The company is operating very inefficient. -2
  • The TTM is -432.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,729.2%TTM-432.3%-1,296.9%
TTM-432.3%YOY-24,646.7%+24,214.4%
TTM-432.3%5Y-5,521.9%+5,089.6%
5Y-5,521.9%10Y-5,259.0%-262.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,729.2%-214.6%-1,514.6%
TTM-432.3%-249.7%-182.6%
YOY-24,646.7%-208.5%-24,438.2%
3Y-9,203.2%-218.7%-8,984.5%
5Y-5,521.9%-342.8%-5,179.1%
10Y-5,259.0%-462.5%-4,796.5%
4.3.2.2. Operating Ratio

Measures how efficient Genelux is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 18.29 means that the operating costs are $18.29 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Genelux Corporation Common Stock:

  • The MRQ is 18.292. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.573. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ18.292TTM4.573+13.719
TTM4.573YOY255.039-250.466
TTM4.5735Y56.474-51.901
5Y56.47410Y53.785+2.689
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ18.2922.093+16.199
TTM4.5732.680+1.893
YOY255.0393.076+251.963
3Y94.1243.518+90.606
5Y56.4744.734+51.740
10Y53.7856.445+47.340
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Genelux Corporation Common Stock.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Genelux is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 4.67Β means the company has $4.67 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Genelux Corporation Common Stock:

  • The MRQ is 4.675. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.432. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.675TTM5.432-0.757
TTM5.432YOY3.403+2.029
TTM5.4325Y2.049+3.383
5Y2.04910Y1.989+0.060
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.6753.616+1.059
TTM5.4323.830+1.602
YOY3.4034.140-0.737
3Y3.0734.688-1.615
5Y2.0495.722-3.673
10Y1.9896.144-4.155
4.4.3.2. Quick Ratio

Measures if Genelux is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Genelux to theΒ Biotechnology industry mean.
  • A Quick Ratio of 7.02Β means the company can pay off $7.02 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Genelux Corporation Common Stock:

  • The MRQ is 7.023. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 9.034. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.023TTM9.034-2.011
TTM9.034YOY4.251+4.782
TTM9.0345Y2.909+6.124
5Y2.90910Y2.808+0.101
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.0232.826+4.197
TTM9.0343.104+5.930
YOY4.2513.786+0.465
3Y4.5284.311+0.217
5Y2.9095.702-2.793
10Y2.8086.335-3.527
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Genelux Corporation Common Stock.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of GeneluxΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Genelux to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.23Β means that Genelux assets areΒ financed with 23.4% credit (debt) and the remaining percentage (100% - 23.4%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Genelux Corporation Common Stock:

  • The MRQ is 0.234. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.206. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.234TTM0.206+0.029
TTM0.206YOY0.319-0.113
TTM0.2065Y2.646-2.441
5Y2.64610Y2.645+0.001
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2340.327-0.093
TTM0.2060.349-0.143
YOY0.3190.332-0.013
3Y1.8240.340+1.484
5Y2.6460.346+2.300
10Y2.6450.378+2.267
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Genelux is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Genelux to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 30.6% means that company has $0.31 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Genelux Corporation Common Stock:

  • The MRQ is 0.306. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.261. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.306TTM0.261+0.045
TTM0.261YOY0.474-0.213
TTM0.2615Y0.369-0.108
5Y0.36910Y0.351+0.018
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3060.383-0.077
TTM0.2610.438-0.177
YOY0.4740.414+0.060
3Y0.6140.450+0.164
5Y0.3690.457-0.088
10Y0.3510.512-0.161
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Genelux generates.

  • Above 15 is considered overpriced butΒ always compareΒ Genelux to theΒ Biotechnology industry mean.
  • A PE ratio of -3.40 means the investor is paying $-3.40Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Genelux Corporation Common Stock:

  • The EOD is -4.256. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.400. Based on the earnings, the company is expensive. -2
  • The TTM is -3.034. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.256MRQ-3.400-0.856
MRQ-3.400TTM-3.034-0.366
TTM-3.034YOY-30.877+27.844
TTM-3.0345Y-8.045+5.011
5Y-8.04510Y-7.662-0.383
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.256-2.416-1.840
MRQ-3.400-2.085-1.315
TTM-3.034-2.620-0.414
YOY-30.877-3.760-27.117
3Y-13.408-3.762-9.646
5Y-8.045-6.363-1.682
10Y-7.662-7.055-0.607
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Genelux Corporation Common Stock:

  • The EOD is -5.835. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.661. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.051. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.835MRQ-4.661-1.174
MRQ-4.661TTM-4.051-0.610
TTM-4.051YOY-37.245+33.194
TTM-4.0515Y-11.044+6.993
5Y-11.04410Y-10.518-0.526
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.835-3.300-2.535
MRQ-4.661-2.737-1.924
TTM-4.051-3.792-0.259
YOY-37.245-4.346-32.899
3Y-18.406-5.095-13.311
5Y-11.044-8.478-2.566
10Y-10.518-9.296-1.222
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Genelux is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 3.41 means the investor is paying $3.41Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Genelux Corporation Common Stock:

  • The EOD is 4.273. Based on the equity, the company is fair priced.
  • The MRQ is 3.414. Based on the equity, the company is fair priced.
  • The TTM is 2.865. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD4.273MRQ3.414+0.860
MRQ3.414TTM2.865+0.549
TTM2.865YOY34.293-31.428
TTM2.8655Y26.881-24.016
5Y26.88110Y25.601+1.280
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.2732.119+2.154
MRQ3.4141.856+1.558
TTM2.8652.125+0.740
YOY34.2932.439+31.854
3Y44.8022.485+42.317
5Y26.8813.667+23.214
10Y25.6014.337+21.264
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Genelux Corporation Common Stock.

4.8.3. Insider Transactions

Insiders are holding 11.857% of the shares of Genelux Corporation Common Stock.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-12-30James L TyreeSELL34602.46
2024-09-13Aladar SzalaySELL330802.57
2024-09-11Aladar SzalaySELL313762.62
2024-09-11James L TyreeSELL17302.6
2024-09-09Aladar SzalaySELL233832.7
2024-09-03Aladar SzalaySELL428182.09
2024-08-29Aladar SzalaySELL1070451.98
2024-08-27Aladar SzalaySELL516302.11
2024-08-23Aladar SzalaySELL400002.29
2024-06-24Caroline JewettSELL49612.12
2024-06-24Sean RyderSELL54962.12
2024-06-24Yong YuSELL68492.12
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets38,985
Total Liabilities9,139
Total Stockholder Equity29,846
 As reported
Total Liabilities 9,139
Total Stockholder Equity+ 29,846
Total Assets = 38,985

Assets

Total Assets38,985
Total Current Assets35,945
Long-term Assets3,040
Total Current Assets
Cash And Cash Equivalents 16,206
Short-term Investments 18,896
Other Current Assets 843
Total Current Assets  (as reported)35,945
Total Current Assets  (calculated)35,945
+/-0
Long-term Assets
Property Plant Equipment 2,967
Long-term Assets Other 73
Long-term Assets  (as reported)3,040
Long-term Assets  (calculated)3,040
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities7,689
Long-term Liabilities1,450
Total Stockholder Equity29,846
Total Current Liabilities
Short-term Debt 337
Accounts payable 6,688
Other Current Liabilities 664
Total Current Liabilities  (as reported)7,689
Total Current Liabilities  (calculated)7,689
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,450
Long-term Liabilities  (as reported)1,450
Long-term Liabilities  (calculated)1,450
+/-0
Total Stockholder Equity
Common Stock38
Retained Earnings -258,885
Accumulated Other Comprehensive Income 29
Other Stockholders Equity 288,664
Total Stockholder Equity (as reported)29,846
Total Stockholder Equity (calculated)29,846
+/-0
Other
Capital Stock38
Cash and Short Term Investments 35,102
Common Stock Shares Outstanding 34,926
Liabilities and Stockholders Equity 38,985
Net Debt -14,419
Net Invested Capital 29,846
Net Working Capital 28,256
Property Plant and Equipment Gross 6,710
Short Long Term Debt Total 1,787



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
3,502
3,502
3,502
3,502
10,611
2,032
2,032
8,126
10,204
9,131
6,189
5,531
14,616
31,363
34,072
27,893
24,676
45,179
40,270
34,716
38,985
38,98534,71640,27045,17924,67627,89334,07231,36314,6165,5316,1899,13110,2048,1262,0322,03210,6113,5023,5023,5023,502
   > Total Current Assets 
2,869
2,869
2,869
2,869
8,293
1,456
1,456
5,822
8,125
6,043
2,861
1,892
12,056
28,683
31,179
24,203
21,204
34,870
35,967
31,548
35,945
35,94531,54835,96734,87021,20424,20331,17928,68312,0561,8922,8616,0438,1255,8221,4561,4568,2932,8692,8692,8692,869
       Cash And Cash Equivalents 
2,838
2,838
2,838
2,838
8,125
1,124
1,124
4,495
7,175
4,202
1,370
397
10,338
27,140
29,869
9,418
4,061
7,858
6,102
8,565
16,206
16,2068,5656,1027,8584,0619,41829,86927,14010,3383971,3704,2027,1754,4951,1241,1248,1252,8382,8382,8382,838
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,773
15,566
25,778
27,955
22,330
18,896
18,89622,33027,95525,77815,56613,773000000000000000
       Other Current Assets 
32
32
32
32
168
332
332
1,327
950
1,841
1,491
1,495
1,718
1,543
1,310
1,012
1,577
1,234
1,910
653
843
8436531,9101,2341,5771,0121,3101,5431,7181,4951,4911,8419501,32733233216832323232
   > Long-term Assets 
633
633
633
633
2,318
576
576
2,304
2,079
3,088
3,328
3,639
2,560
2,680
2,893
3,690
3,472
10,309
4,303
3,168
3,040
3,0403,1684,30310,3093,4723,6902,8932,6802,5603,6393,3283,0882,0792,3045765762,318633633633633
       Property Plant Equipment 
613
613
613
613
2,238
553
553
2,212
1,987
2,432
2,223
1,979
2,468
2,588
2,801
3,598
3,380
3,404
3,208
3,076
2,967
2,9673,0763,2083,4043,3803,5982,8012,5882,4681,9792,2232,4321,9872,2125535532,238613613613613
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,813
1,003
0
0
001,0036,81300000000000000000
       Long-term Assets Other 
20
20
20
20
80
23
23
92
92
656
1,105
1,660
92
92
92
92
92
92
92
92
73
7392929292929292921,6601,105656929223238020202020
> Total Liabilities 
9,166
9,166
9,166
9,166
35,849
10,309
10,309
41,237
46,744
48,194
38,520
41,314
11,925
9,107
10,044
8,420
9,592
7,510
7,179
8,442
9,139
9,1398,4427,1797,5109,5928,42010,0449,10711,92541,31438,52048,19446,74441,23710,30910,30935,8499,1669,1669,1669,166
   > Total Current Liabilities 
3,623
3,623
3,623
3,623
12,302
5,621
5,621
22,483
29,455
30,564
21,448
31,626
10,543
7,878
8,755
6,554
7,805
5,803
5,555
6,903
7,689
7,6896,9035,5555,8037,8056,5548,7557,87810,54331,62621,44830,56429,45522,4835,6215,62112,3023,6233,6233,6233,623
       Short-term Debt 
901
901
901
901
2,421
1,539
1,539
6,557
7,861
7,838
8,346
16,931
2,233
1,235
1,174
1,306
584
1,000
415
329
337
3373294151,0005841,3061,1741,2352,23316,9318,3467,8387,8616,5571,5391,5392,421901901901901
       Short Long Term Debt 
0
0
0
0
0
0
0
6,155
7,430
7,480
8,033
16,399
1,665
65
40
0
0
0
0
0
0
00000040651,66516,3998,0337,4807,4306,1550000000
       Accounts payable 
927
927
927
927
1,116
1,116
1,116
4,462
4,469
5,402
5,352
6,775
5,292
4,484
4,009
3,784
5,313
4,786
4,454
5,570
6,688
6,6885,5704,4544,7865,3133,7844,0094,4845,2926,7755,3525,4024,4694,4621,1161,1161,116927927927927
       Other Current Liabilities 
1,795
1,795
1,795
1,795
7,641
1,842
1,842
6,964
7,165
7,364
7,690
7,750
3,018
2,159
3,572
1,464
1,908
17
1,101
1,004
664
6641,0041,101171,9081,4643,5722,1593,0187,7507,6907,3647,1656,9641,8421,8427,6411,7951,7951,7951,795
   > Long-term Liabilities 
5,543
5,543
5,543
5,543
23,547
4,689
4,689
18,754
17,289
17,630
17,072
9,688
1,382
1,229
1,289
1,866
1,787
1,707
1,624
1,539
1,450
1,4501,5391,6241,7071,7871,8661,2891,2291,3829,68817,07217,63017,28918,7544,6894,68923,5475,5435,5435,5435,543
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
1,013
1,568
0
0
0
0
0
0
0
0
0
0000000001,5681,0130000000000
> Total Stockholder Equity
-5,664
-5,664
-5,664
-5,664
-25,238
-8,278
-8,278
-33,111
-36,540
-39,063
-32,331
-35,783
2,691
22,256
24,028
19,473
15,084
37,669
33,091
26,274
29,846
29,84626,27433,09137,66915,08419,47324,02822,2562,691-35,783-32,331-39,063-36,540-33,111-8,278-8,278-25,238-5,664-5,664-5,664-5,664
   Common Stock
2
2
2
2
27
2
2
9
27
9
9
9
25
26
27
27
27
35
35
35
38
38353535272727262599927922272222
   Retained Earnings -258,885-251,393-242,417-235,950-229,374-221,524-214,757-209,412-203,591-189,784-186,289-191,198-188,378-184,577-46,144-46,144-171,198-42,057-42,057-42,057-42,057
   Accumulated Other Comprehensive Income 
-461
-461
-461
-461
2
-599
-599
2
2
2
2
2
2
2
2
14
-5
-11
124
64
29
2964124-11-51422222222-599-5992-461-461-461-461
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
206,688
232,073
0
0
0
0
0
0
0
0000000232,073206,688000000000000
   Treasury Stock0000000-433-433000000000000
   Other Stockholders Equity 
36,852
36,852
36,852
36,852
145,909
38,464
38,464
151,433
151,787
152,102
153,925
153,968
206,255
231,640
238,756
240,956
244,436
273,595
275,349
277,568
288,664
288,664277,568275,349273,595244,436240,956238,756231,640206,255153,968153,925152,102151,787151,43338,46438,464145,90936,85236,85236,85236,852



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue8
Cost of Revenue-0
Gross Profit88
 
Operating Income (+$)
Gross Profit8
Operating Expense-31,704
Operating Income-31,696-31,696
 
Operating Expense (+$)
Research Development18,998
Selling General Administrative12,706
Selling And Marketing Expenses0
Operating Expense31,70431,704
 
Net Interest Income (+$)
Interest Income1,457
Interest Expense-0
Other Finance Cost-0
Net Interest Income1,457
 
Pretax Income (+$)
Operating Income-31,696
Net Interest Income1,457
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-29,869-33,523
EBIT - interestExpense = -29,869
-29,869
-29,869
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-29,869-29,869
Earnings Before Interest and Taxes (EBITDA)-28,966
 
After tax Income (+$)
Income Before Tax-29,869
Tax Provision-0
Net Income From Continuing Ops-29,869-29,869
Net Income-29,869
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses31,704
Total Other Income/Expenses Net1,827-1,457
 

Technical Analysis of Genelux
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Genelux. The general trend of Genelux is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Genelux's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Genelux Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Genelux Corporation Common Stock.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 4.05 < 4.37 < 5.67.

The bearish price targets are: 3.35 > 3.29 > 3.17.

Know someone who trades $GNLX? Share this with them.πŸ‘‡

Genelux Corporation Common Stock Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Genelux Corporation Common Stock. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Genelux Corporation Common Stock Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Genelux Corporation Common Stock. The current macd is 0.17695378.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Genelux price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Genelux. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Genelux price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Genelux Corporation Common Stock Daily Moving Average Convergence/Divergence (MACD) ChartGenelux Corporation Common Stock Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Genelux Corporation Common Stock. The current adx is 36.26.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Genelux shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Genelux Corporation Common Stock Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Genelux Corporation Common Stock. The current sar is 2.93172471.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Genelux Corporation Common Stock Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Genelux Corporation Common Stock. The current rsi is 63.13. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Genelux Corporation Common Stock Daily Relative Strength Index (RSI) ChartGenelux Corporation Common Stock Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Genelux Corporation Common Stock. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Genelux price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Genelux Corporation Common Stock Daily Stochastic Oscillator ChartGenelux Corporation Common Stock Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Genelux Corporation Common Stock. The current cci is 103.17.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Genelux Corporation Common Stock Daily Commodity Channel Index (CCI) ChartGenelux Corporation Common Stock Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Genelux Corporation Common Stock. The current cmo is 31.73.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Genelux Corporation Common Stock Daily Chande Momentum Oscillator (CMO) ChartGenelux Corporation Common Stock Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Genelux Corporation Common Stock. The current willr is -26.74418605.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Genelux is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Genelux Corporation Common Stock Daily Williams %R ChartGenelux Corporation Common Stock Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Genelux Corporation Common Stock.

Genelux Corporation Common Stock Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Genelux Corporation Common Stock. The current atr is 0.23460482.

Genelux Corporation Common Stock Daily Average True Range (ATR) ChartGenelux Corporation Common Stock Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Genelux Corporation Common Stock. The current obv is -4,178,933.

Genelux Corporation Common Stock Daily On-Balance Volume (OBV) ChartGenelux Corporation Common Stock Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Genelux Corporation Common Stock. The current mfi is 61.26.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Genelux Corporation Common Stock Daily Money Flow Index (MFI) ChartGenelux Corporation Common Stock Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Genelux Corporation Common Stock.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-03-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-03-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-31STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-04-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-10STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Genelux Corporation Common Stock Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Genelux Corporation Common Stock based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.130
Ma 20Greater thanMa 503.067
Ma 50Greater thanMa 1002.759
Ma 100Greater thanMa 2003.054
OpenGreater thanClose3.410
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Genelux with someone you think should read this too:
  • Are you bullish or bearish on Genelux? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Genelux? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Genelux Corporation Common Stock

I send you an email if I find something interesting about Genelux Corporation Common Stock.


Comments

How you think about this?

Leave a comment

Stay informed about Genelux Corporation Common Stock.

Receive notifications about Genelux Corporation Common Stock in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.